官方服务：
资源简介：
Pathways differentially expressed between CMS2 and other subtypes.
应用场景：
创建时间：
2019-08-22
相关数据集
Additional file 1: of Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer
The 18 gene RAS scores, and KRAS/BRAF/NRAS mutation status for 54 CRC samples (15 “bad” samples are in bold; PC1: the first principal component; PC2: the second principal component; 1 = mutation prese
Figshare2017-03-10 更新50
Table1_Exploration of the ubiquitination-related molecular classification and signature to predict the survival and immune microenvironment in colon cancer.XLSX
BackgroundUbiquitination, a major post-translational modification, significantly impacts tumorigenesis, progression, and prognosis. This study aims to classify colon cancer at the molecular level and
NIAID Data Ecosystem10
Comparison of clinical profile with the combinatorial effect of variations in genes in 62 patients with sporadic CRC.
*variation refers to genetic mutation in Kras gene and/or epigenetic modification in RASSF1A, FHIT and MGMT genes.p value
Figshare2015-12-02 更新10
Top Pathway ANOVA KEGG gene sets showing effects due to main effect of ethanol vs saline treatment.
Top Pathway ANOVA KEGG gene sets showing effects due to main effect of ethanol vs saline treatment.
NIAID Data Ecosystem20
Additional file 4 of Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
Additional file 4: Table S4. Twenty-eight immune cells and corresponding gene signatures.
Figshare2024-02-13 更新10
